Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Lamy Patrick
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | 4:持股變動聲明-高管 White William Richard
Akero Therapeutics | 4:持股變動聲明-高管 Gangloff Scott A.
Akero Therapeutics | 4:持股變動聲明-高管 Rolph Timothy
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 144:擬議出售證券
Akero Therapeutics | 4:持股變動聲明-高管 Rolph Timothy
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Lamy Patrick
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | 4:持股變動聲明-高管 White William Richard
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 144:擬議出售證券
Akero Therapeutics | 4:持股變動聲明-高管 Cheng Andrew
Akero Therapeutics | 4:持股變動聲明-高管 Young Jonathan
Akero Therapeutics | 4:持股變動聲明-高管 Yale Catriona
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Janus Henderson Group plc(10.2%)
Akero Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(5.5%)
暫無數據